Cisplatin
What's New
Last Posted: May 25, 2023
- Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives.
Mark G Kris et al. Transl Lung Cancer Res 2023 12(4) 824-836 - A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives.
Samuel Workman et al. AME medical journal 2023 8 - A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy.
Guo Yupeng et al. Aging 2022 14 - Role of genetic testing in hepatic, pancreatic, and biliary cancers.
Hewitt D Brock et al. Surgical oncology 2022 44101844 - Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma.
Graf Ryon P et al. JCO precision oncology 2022 6e2200121 - Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer - results from the phase III OVHIPEC trial.
Koole Simone N et al. International journal of cancer 2022 - Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.
Burton Kimberly A et al. JCO precision oncology 2022 6e2100280 - Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
Trendowski Matthew R et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Sep - Evaluation of the Role of ITGBL1 in Ovarian Cancer.
Cortez Alexander Jorge et al. Cancers 2020 Sep 12(9) - Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.
Langer Thorsten et al. Data in brief 2020 Oct 32106227
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: